A rare case of vestibular schwannoma manifesting as trigeminal neuralgia
J Am Dent Assoc. 2023 Nov 29:S0002-8177(23)00621-9. doi: 10.1016/j.adaj.2023.10.004. Online ahead of print.ABSTRACTBACKGROUND: In this case report, the authors reviewed a rare case of a vestibular schwannoma manifesting as trigeminal neuralgia (TN). Intracranial tumors can have a variety of orofacial pain symptoms. Among benign cerebellopontine angle tumors, vestibular schwannoma is the most common cause of a TN-like manifestation. Although the most common symptoms of a vestibular schwannoma are hearing loss and vestibulopathy, the unique feature of this case was the manifestation of symptoms consistent with TN.CASE DESCRI...
Source: Journal of the American Dental Association - November 30, 2023 Category: Dentistry Authors: Sowmya Ananthan Upasana Kumar Stephen Johnson Source Type: research

A Hidden Pandemic? Abuse of Gabapentinoids: A Brief Review of Recent Studies
CONCLUSION: Gabapentinoids are highly abused molecules worldwide. Physicians should be aware of their abuse potential.PMID:38031769 | DOI:10.2174/0125899775268780231002064605 (Source: Epilepsy Curr)
Source: Epilepsy Curr - November 30, 2023 Category: Neurology Authors: Gamze Zengin İspir Mustafa Dan ışman K übra Sezer Katar Source Type: research

A rare case of vestibular schwannoma manifesting as trigeminal neuralgia
J Am Dent Assoc. 2023 Nov 29:S0002-8177(23)00621-9. doi: 10.1016/j.adaj.2023.10.004. Online ahead of print.ABSTRACTBACKGROUND: In this case report, the authors reviewed a rare case of a vestibular schwannoma manifesting as trigeminal neuralgia (TN). Intracranial tumors can have a variety of orofacial pain symptoms. Among benign cerebellopontine angle tumors, vestibular schwannoma is the most common cause of a TN-like manifestation. Although the most common symptoms of a vestibular schwannoma are hearing loss and vestibulopathy, the unique feature of this case was the manifestation of symptoms consistent with TN.CASE DESCRI...
Source: Journal of the American Dental Association - November 30, 2023 Category: Dentistry Authors: Sowmya Ananthan Upasana Kumar Stephen Johnson Source Type: research

A Hidden Pandemic? Abuse of Gabapentinoids: A Brief Review of Recent Studies
CONCLUSION: Gabapentinoids are highly abused molecules worldwide. Physicians should be aware of their abuse potential.PMID:38031769 | DOI:10.2174/0125899775268780231002064605 (Source: Epilepsy Curr)
Source: Epilepsy Curr - November 30, 2023 Category: Neurology Authors: Gamze Zengin İspir Mustafa Dan ışman K übra Sezer Katar Source Type: research

A rare case of vestibular schwannoma manifesting as trigeminal neuralgia
J Am Dent Assoc. 2023 Nov 29:S0002-8177(23)00621-9. doi: 10.1016/j.adaj.2023.10.004. Online ahead of print.ABSTRACTBACKGROUND: In this case report, the authors reviewed a rare case of a vestibular schwannoma manifesting as trigeminal neuralgia (TN). Intracranial tumors can have a variety of orofacial pain symptoms. Among benign cerebellopontine angle tumors, vestibular schwannoma is the most common cause of a TN-like manifestation. Although the most common symptoms of a vestibular schwannoma are hearing loss and vestibulopathy, the unique feature of this case was the manifestation of symptoms consistent with TN.CASE DESCRI...
Source: Journal of the American Dental Association - November 30, 2023 Category: Dentistry Authors: Sowmya Ananthan Upasana Kumar Stephen Johnson Source Type: research

Efficacy and safety of pregabalin and gabapentin in spinal stenosis: a systematic review and meta-analysis
Conclusion: Our meta-analysis suggests that abapentinoids may have a significant effect on VAS score at 3 months, but no significant differences were observed in ODI scores, and adverse events were higher in the gabapentinoids group. (Source: Frontiers in Pharmacology)
Source: Frontiers in Pharmacology - November 29, 2023 Category: Drugs & Pharmacology Source Type: research

Gabapentin for pain in pediatric palliative care
This study describes the real-world use of gabapentin and the associated benefits and adverse effects/events (AEs). (Source: Journal of Pain and Symptom Management)
Source: Journal of Pain and Symptom Management - November 28, 2023 Category: Palliative Care Authors: Ross Drake, Grace Prael, Yinyin Phyo, Sungwon Chang, Jane Hunt, Anthony Herbert, Christine Mott, Jenny Hynson, Marianne Phillips, Mary Cossich, Martha Mherekumombe, Min Sun Kim, Poh Heng Chong, Maja Abitz, Mercedes Bernada, Madeline Avery, Matt Doogue, De Tags: Original Article Source Type: research

Topical Nigella sativa L. product: a new candidate for the management of diabetic peripheral neuropathy
ConclusionAccording to the results of this study, the topical use ofN. sativa, compared to the current drugs, has acceptable improving effects on diabetic neuropathic patients. (Source: Inflammopharmacology)
Source: Inflammopharmacology - November 13, 2023 Category: Drugs & Pharmacology Source Type: research

Metformin alleviates pathologic pain in mice with radiation dermatitis by inhibiting p38MAPK/NF- κB signaling pathway
CONCLUSION: Metformin can significantly ameliorate pathological pain symptoms in mice with radiation dermatitis possibly by inhibiting the activation of p38MAPK/NF-κB signaling pathway.PMID:37933660 | DOI:10.12122/j.issn.1673-4254.2023.10.22 (Source: Journal of Southern Medical University)
Source: Journal of Southern Medical University - November 7, 2023 Category: Universities & Medical Training Authors: J Cao H Liu Q An F Han Source Type: research

Metformin alleviates pathologic pain in mice with radiation dermatitis by inhibiting p38MAPK/NF- κB signaling pathway
CONCLUSION: Metformin can significantly ameliorate pathological pain symptoms in mice with radiation dermatitis possibly by inhibiting the activation of p38MAPK/NF-κB signaling pathway.PMID:37933660 | PMC:PMC10630197 | DOI:10.12122/j.issn.1673-4254.2023.10.22 (Source: Journal of Southern Medical University)
Source: Journal of Southern Medical University - November 7, 2023 Category: Universities & Medical Training Authors: J Cao H Liu Q An F Han Source Type: research

Metformin alleviates pathologic pain in mice with radiation dermatitis by inhibiting p38MAPK/NF- κB signaling pathway
CONCLUSION: Metformin can significantly ameliorate pathological pain symptoms in mice with radiation dermatitis possibly by inhibiting the activation of p38MAPK/NF-κB signaling pathway.PMID:37933660 | PMC:PMC10630197 | DOI:10.12122/j.issn.1673-4254.2023.10.22 (Source: Journal of Southern Medical University)
Source: Journal of Southern Medical University - November 7, 2023 Category: Universities & Medical Training Authors: J Cao H Liu Q An F Han Source Type: research

Metformin alleviates pathologic pain in mice with radiation dermatitis by inhibiting p38MAPK/NF- κB signaling pathway
CONCLUSION: Metformin can significantly ameliorate pathological pain symptoms in mice with radiation dermatitis possibly by inhibiting the activation of p38MAPK/NF-κB signaling pathway.PMID:37933660 | PMC:PMC10630197 | DOI:10.12122/j.issn.1673-4254.2023.10.22 (Source: Journal of Southern Medical University)
Source: Journal of Southern Medical University - November 7, 2023 Category: Universities & Medical Training Authors: J Cao H Liu Q An F Han Source Type: research

Metformin alleviates pathologic pain in mice with radiation dermatitis by inhibiting p38MAPK/NF- κB signaling pathway
CONCLUSION: Metformin can significantly ameliorate pathological pain symptoms in mice with radiation dermatitis possibly by inhibiting the activation of p38MAPK/NF-κB signaling pathway.PMID:37933660 | PMC:PMC10630197 | DOI:10.12122/j.issn.1673-4254.2023.10.22 (Source: Journal of Southern Medical University)
Source: Journal of Southern Medical University - November 7, 2023 Category: Universities & Medical Training Authors: J Cao H Liu Q An F Han Source Type: research

Metformin alleviates pathologic pain in mice with radiation dermatitis by inhibiting p38MAPK/NF- κB signaling pathway
CONCLUSION: Metformin can significantly ameliorate pathological pain symptoms in mice with radiation dermatitis possibly by inhibiting the activation of p38MAPK/NF-κB signaling pathway.PMID:37933660 | PMC:PMC10630197 | DOI:10.12122/j.issn.1673-4254.2023.10.22 (Source: Journal of Southern Medical University)
Source: Journal of Southern Medical University - November 7, 2023 Category: Universities & Medical Training Authors: J Cao H Liu Q An F Han Source Type: research

Metformin alleviates pathologic pain in mice with radiation dermatitis by inhibiting p38MAPK/NF- κB signaling pathway
CONCLUSION: Metformin can significantly ameliorate pathological pain symptoms in mice with radiation dermatitis possibly by inhibiting the activation of p38MAPK/NF-κB signaling pathway.PMID:37933660 | PMC:PMC10630197 | DOI:10.12122/j.issn.1673-4254.2023.10.22 (Source: Journal of Southern Medical University)
Source: Journal of Southern Medical University - November 7, 2023 Category: Universities & Medical Training Authors: J Cao H Liu Q An F Han Source Type: research